---
title: "WKD \xD7 DNA KEY Module: Phased Development \\& Test Blueprint"
slug: wkd-dna-key-module-phased-development-test-blueprint
status: draft
created: '2026-03-20'
updated: '2026-03-20'
version: 0.1.0
tags:
- multiplicity
traceability:
  path: 05-systems/engines/wkd/WKD_Phased Dev Blueprint.md
  last_synced: '2026-03-20T17:17:18.347564Z'
---

# WKD × DNA KEY Module: Phased Development \& Test Blueprint

This blueprint translates the full WKD footprint—spanning the patent specifications (R2, R3, R5), the FIG. 6 Software Architecture, the ECP claims architecture, and the expert declarations—into a buildable, testable engineering plan across five phases.

***

## Phase 1 — Foundation: WKD Knowledge Graph \& Ontology Layer

**Goal:** Stand up the three-layer semantic architecture (Data → Knowledge → Wisdom) that is the backbone of WKD's explainability claim.[^1]

### 1.1 Knowledge Ontology Design

- Define the **WKD Ontology Schema** covering four domain namespaces: `ros:` (ROS biochemistry), `snp:` (genomic variants), `nutr:` (nutritional interventions), `clin:` (clinical literature)
- Each WKD Knowledge Node must carry: node ID, PubMed citation URI, evidence grade (RCT/meta-analysis/mechanistic), confidence weight, and last-verified timestamp[^2]
- Seed the ontology with the patent's four-step mechanistic inference chain: HRV→sympathetic activation (Thayer 2012), sympathetic→NOX2 ROS (Deo 2012), ROS→biophoton (Cifra 2014), combinatorial proxy validity[^3]


### 1.2 Knowledge Node Population

- Populate **Tier 1 nodes** (directly cited in patent): SOD2 rs4880, GPX1 rs1050450, CAT rs1001179, NQO1 rs1800566 with pathway vulnerability scores V(i) ∈ {0.0, 0.5, 1.0}[^2]
- Populate **Tier 2 nodes**: component-pathway mappings (NAC→SOD2/mitochondrial superoxide, selenomethionine→GPX1/H₂O₂, CoQ10→NQO1/quinone, ascorbic acid→general ROS)[^3]
- Populate **Tier 3 nodes**: dosage adjustment formulas (factor = 1 + 0.5 × V(i)) and base dosage tables from patent Table 2[^2]


### 1.3 Three-Layer Semantic Enforcement

Per Claim 22 in the ECP architecture, implement strict layer separation:[^1]


| Layer | Content | Enforcement Rule |
| :-- | :-- | :-- |
| **Data** | Raw sensor streams (HRV, EDA, BioZ), genomic SNP calls | No interpretation; immutable ingestion |
| **Knowledge** | ACFL predicates, CRMF scores, EPI values | Derived only from Data layer via declared transforms |
| **Wisdom** | Intervention recommendations with confidence, clinical citations | Generated only from Knowledge layer; requires provenance chain |

### 1.4 Deliverables \& Tests

- **Unit test:** Every Wisdom-layer node traces back through ≥1 Knowledge node to ≥1 Data node (provenance chain completeness = 100%)
- **Schema validation test:** All knowledge nodes conform to ontology; no orphan nodes
- **Acceptance criterion:** Graph query returns full reasoning chain for any recommendation in <200ms

***

## Phase 2 — ACFL Engine: Compensatory Fuzzy Logic Core

**Goal:** Implement the Archimedean Compensatory Fuzzy Logic engine that processes CRMF output into health predicates with categorical truth values.[^4][^2]

### 2.1 Archimedean T-Norm Generator

- Implement parameterized generator function with base `b` and exponent `n` (TS-14 trade secret boundary: exact values server-side only; ranges disclosed for enablement)[^2]
- The engine must **automatically select its logic family from data** — different datasets require different generating functions (BUPA: log base 3.71 / n=1; Car: log base 2.01 / n=15)[^2]
- Implement **compensatory conjunction** (Archimedean t-norm) and **compensatory disjunction** for multi-criteria evaluation


### 2.2 Health Predicate Library

Build the five named ACFL predicates from Claim 3:[^1]

1. `EPI_RISK` — phase transition proximity from EPI trajectory
2. `ROS_BURDEN` — γ(t) magnitude and velocity (dEPI/dt)
3. `GENOMIC_SUSCEPTIBILITY` — CRMF e(t) composite score
4. `ANTIOXIDANT_CAPACITY` — α(t) from bioimpedance phase angle at 200 kHz
5. `NEGENTROPY_TREND` — N(t) trajectory (coherence + entropy + Mandel Q proxy)

### 2.3 Categorical Truth Scale Mapping

Map every ACFL computation to natural language truth values:[^4]

- 0.7 → "somewhat true"
- 0.8 → "enough true"
- 0.9 → "almost true"
- 1.0 → "true"
- 0.0 triggers **veto axiom** (if any component is zero, the entire conjunction is zero)[^2]


### 2.4 ACFL Compound Truth Value Computation

For CRMF decisional logic, implement: T_compound = C(V₁, V₂, …, Vₖ), where C is the ACFL compensatory conjunction operator; select components maximizing T_compound with constraint ≥2 components selected.[^3]

### 2.5 Deliverables \& Tests

- **Veto axiom test:** Any single input = 0 → output = 0 (100% enforcement)
- **Compensation test:** With V₁=0.3, V₂=0.9, verify output > min(V₁,V₂) (compensatory property holds)
- **Benchmark:** Replicate BUPA dataset truth value 0.995 and Car dataset 0.93 from Espín-Andrade publications[^2]
- **Regression:** Verify 88% practitioner agreement threshold on test predicate set[^4]

***

## Phase 3 — Wasserstein Knowledge Distillation \& Teacher-Student Architecture

**Goal:** Implement the FIG. 6 component 620 (WKD) with its five sub-modules for model compression and knowledge transfer to edge devices.[^5]

### 3.1 Sub-Module Implementation

| FIG. 6 ID | Module | Implementation |
| :-- | :-- | :-- |
| 621 | Teacher Model Ensemble | Server-side full ACFL + CRMF + PT-symmetric pipeline; ensemble of calibrated models |
| 622 | Student Model | Edge-optimized model for ARM Cortex-M55 + Ethos-U55 NPU (256 MACs/cycle) [^1] |
| 623 | Wasserstein Distance Calculator | Discrete WD for logit distillation (cross-category probability comparison); continuous WD for intermediate feature layers |
| 624 | Knowledge Transfer Engine | Orchestrates teacher→student distillation cycles; schedules retraining triggers from HITL feedback (module 635) |
| 625 | Optimal Transport Pathway Selector | Selects minimal-cost transport plan mapping teacher distributions to student capacity constraints |

### 3.2 Edge-Cloud Partitioning

Per the trade secret boundary (TS-13, TS-14), exact coefficient values and CCRE refinement computations remain **server-side only**:[^3][^2]

- **Edge (ring):** Student model runs on-device ACFL predicate evaluation, EPI threshold check, FREEZE-RESONANCE trigger
- **Cloud:** Teacher ensemble, CCRE contraction certification, Wasserstein distillation, coefficient optimization, Merkle-linked provenance DAG


### 3.3 Distillation Training Protocol

1. Train teacher ensemble on ECP pilot dataset (n=50–60, genotype-stratified)[^6]
2. Compute discrete WD between teacher logits and student logits for each ACFL predicate
3. Minimize total transport cost while preserving categorical truth scale fidelity (student must reproduce teacher's truth value within ±0.05)
4. Validate student model preserves veto axiom and compensatory property post-distillation

### 3.4 Deliverables \& Tests

- **Fidelity test:** Student model truth values within ±0.05 of teacher for all 5 predicates across validation set
- **Latency test:** On-device ACFL predicate evaluation <50ms on Cortex-M55
- **Memory test:** Student model fits within 512 KB SRAM budget[^1]
- **Distillation convergence:** WD loss decreases monotonically over training epochs

***

## Phase 4 — CCRE Governance Integration \& HITL Pipeline

**Goal:** Wire the CCRE resonance-modulated gain layer so "ACFL proposes, CRMF gates", and build the practitioner-facing HITL interface from FIG. 6 component 630.[^5][^3]

### 4.1 CCRE-Gated ACFL Output

Implement the gain function from the patent specification:[^4][^3]

$$
m(t) = \text{CSC-clamp}[\text{raw}(t)] \cdot g(R(t))
$$

where $g(R(t)) = 1 + \alpha(R(t) - 0.5)$ with $\alpha = 0.2$ (disclosed range [0.1, 0.3])

- R(t) > 0.7 → gain **amplifies** ACFL-WKD output
- R(t) < 0.3 → gain **attenuates** toward zero
- R(t) exits safe band → **FREEZE-RESONANCE** activated (output zeroed, all updates inhibited, EXECUTION→SILENT logged)


### 4.2 Contraction Certification Gate

Every ACFL parameter update via practitioner feedback must satisfy:[^3]

- Lipschitz constant L(T) < 1 (Banach fixed-point contraction)
- Cumulative drift (SBERT cosine distance) < 0.3
- Coefficients remain within disclosed ranges: c_r ∈ [0.25, 0.40], c_a ∈ [0.15, 0.25], c_e ∈ [0.03, 0.08]
- On pass → apply update + emit **CRMF Witness Object** (transform ID, input hash, output hash, Lipschitz bound, resonance status, verification hash → Merkle-linked into provenance DAG)
- On fail → FREEZE-RESONANCE


### 4.3 HITL Interface (FIG. 6 Component 630)

Build the six sub-modules from the architecture diagram:[^5]

1. **Clinician Review Portal (631):** Displays full WKD reasoning chain: Sensor Data → ACFL Predicate → WKD Knowledge Node → PubMed Citation → Recommendation
2. **Feedback Integration Loop (632):** Captures practitioner corrections as CCRE-class supervised learning inputs
3. **Alert Triage Engine (633):** Prioritizes intervention recommendations by EPI severity and CRMF genomic susceptibility
4. **Intervention Override Control (634):** Mandatory HITL approval gate before any intervention deploys to end user
5. **Model Retraining Trigger (635):** Fires when accumulated practitioner corrections exceed retraining threshold → initiates Phase 3 distillation cycle
6. **Audit Log / Explainability (636) + Regulatory Compliance (637):** SHA-256 hash chain (Claim 17 ), 21 CFR Part 11 compliance, FDA CDS transparency[^1]

### 4.4 Deliverables \& Tests

- **FREEZE-RESONANCE test:** Inject R(t) = 0.1 → verify output = 0.0 within 1 computation cycle
- **Contraction violation test:** Propose update with L(T) = 1.2 → verify rejection and EXECUTION→SILENT log entry
- **Drift bound test:** Simulate 100 sequential updates → verify cumulative SBERT drift never exceeds 0.3
- **HITL round-trip test:** Practitioner correction → CCRE certification → student model update → WKD provenance chain updated (end-to-end <5 min)
- **Audit integrity test:** Tamper with any Merkle node → verify hash chain invalidation detected

***

## Phase 5 — End-to-End Integration, Validation \& Regulatory Readiness

**Goal:** Wire all components into the complete pipeline matching the patent's closed-loop system, validate against worked examples, and prepare for ECP Phase 1 and FDA CDS pathway.

### 5.1 Full Pipeline Integration

Assemble the complete data flow as described across R2/R3/R5:[^4][^3][^2]

```
Ring Sensors (PPG/EDA/BioZ)
    → γ(t), κ(t), N(t) computation
        → PT-Symmetric Hamiltonian → EPI(t)
            → CRMF genomic profile → e(t)
                → ACFL 5-predicate evaluation
                    → WKD Knowledge Node resolution (PubMed provenance)
                        → CCRE gain gate [m(t)]
                            → HITL practitioner portal
                                → Intervention deployment (if approved)
                                    → Post-intervention EPI monitoring (closed loop)
```


### 5.2 Worked Example Regression Suite

Reproduce **all patent worked examples** as automated integration tests:


| Example | Subject | Key Validation |
| :-- | :-- | :-- |
| Section VIII-A (non-prophetic) | 48yo male, SOD2 ValAla | r = 0.73 correlation with biomarkers, coefficients c_r=0.33, c_a=0.19, c_e=0.06 within ranges [^3] |
| Prophetic Ex. 1 | 52yo male, SOD2 ValVal | EPI decline Weeks 0–4, intervention trigger at Week 2–4, recovery by Week 8 [^3] |
| Prophetic Ex. 2 | 45yo female, GPX1 LeuLeu | Selenium doubled to 400μg/day, recovery by Week 7 [^3] |
| Prophetic Ex. 3 | 38yo male, acute stressor | EPI drop within 72h, acute protocol activation [^3] |

### 5.3 WKD-Specific Acceptance Criteria

- **Provenance completeness:** 100% of recommendations trace to ≥1 PubMed citation
- **Explainability format:** Every output matches template: *"Based on [EPI trajectory data], [CRMF genomic profile], and [N(t) trend], the system assesses [health predicate] with confidence [0–1] and recommends [intervention] with compensatory weight w"*[^2]
- **FDA CDS compliance:** Practitioner can independently review the basis for every recommendation (21 CFR Part 11, FDA CDS guidance)[^2]
- **AUROC target:** Binary EPI threshold decision achieves AUROC ≥ 0.85 (implied by r = 0.73 per Hanley \& McNeil 1982)[^3]


### 5.4 ECP Phase 1 Alignment

Per the Gap 3 resolution document, the WKD module must support the ECP Phase 1 study protocol (n=50–60):[^6]

- Genotype-stratified cohort support (SOD2, GPX1, CAT, NQO1 variant groups)
- 7-day baseline + longitudinal monitoring data pipelines
- Concurrent biomarker panel integration (F₂-isoprostanes, 8-OHdG)
- Residual diagnostics output (circadian 15–20%, dietary 10–15%, stochastic 10–15%)[^3]


### 5.5 Dual Regulatory Mode (Claim 28)

Implement configurable regulatory posture:[^1]

- **Wellness mode (§520(o)):** General wellness claims, no HITL gate required, limited WKD output (no dosage specificity)
- **SaMD mode (510(k)):** Full HITL gate, complete WKD provenance chain, SHA-256 audit log, FDA CDS transparency enforced


### 5.6 Security \& Trade Secret Boundary

- All TS-13 (exact coefficients), TS-14 (ACFL generator parameters), TS-15 (negentropy weights) computed **server-side only** via Edge-Cloud Sync Manager (FIG. 6 component 640)[^5]
- AES-256 encryption on all BLE transmissions (Claim 29)[^1]
- API Gateway (641) enforces zero-knowledge boundary: ring device never receives raw coefficient values

***

## Implementation Timeline

| Phase | Duration | Dependencies | Key Milestone |
| :-- | :-- | :-- | :-- |
| **Phase 1** — Ontology \& Knowledge Graph | Weeks 1–4 | None | Seed graph with all patent-cited nodes; provenance query <200ms |
| **Phase 2** — ACFL Engine | Weeks 3–8 | Phase 1 schema | 5 predicates operational; veto axiom + compensation verified |
| **Phase 3** — WKD Distillation | Weeks 7–14 | Phase 2 ACFL engine | Student model on Cortex-M55; ±0.05 fidelity to teacher |
| **Phase 4** — CCRE + HITL | Weeks 10–18 | Phases 2–3 | FREEZE-RESONANCE tested; practitioner portal functional |
| **Phase 5** — Integration \& Validation | Weeks 16–24 | All phases | All worked examples pass; ECP Phase 1 ready; dual regulatory mode |

This gives you a **24-week critical path** from ontology design through ECP-ready deployment, with Phases 1–2 and 3–4 partially parallelizable to compress the timeline where resources allow.
<span style="display:none">[^10][^11][^12][^13][^14][^15][^16][^17][^18][^19][^20][^21][^22][^23][^24][^25][^26][^27][^28][^29][^30][^31][^32][^33][^34][^35][^36][^37][^38][^39][^40][^41][^42][^43][^44][^45][^46][^47][^48][^49][^50][^51][^7][^8][^9]</span>

<div align="center">⁂</div>

[^1]: ECP-WORKFLOW-INTEGRATION-CLAIMS-ARCHITECTURE-WORKED-EXAMPLES-ENABLEMENT.pdf

[^2]: DNA-KEY-INTRINSICA-R3-Patent.md

[^3]: ROS_Provisional_R2_Patent.md

[^4]: R5_Patent_Part3.md

[^5]: Figure-6-Software-Architecture-ACFL-WKD-HITL-.drawio.pdf

[^6]: ROS R3 — Gap 3 ECP Phase 1.docx

[^7]: ROS Provisional Patent R3.docx

[^8]: Claude Opus 4.6 Thinking-response.md

[^9]: Council Model Analysis_ ROS-Mediated Biological Ph.docx

[^10]: ROS Provisional R3 — Gap 1 Resolution.docx

[^11]: ROS R3 — Gap 2 Lightning Rod.docx

[^12]: ROS R3 — Gap 4 PCT Strategy.docx

[^13]: R5_Patent_Part2.md

[^14]: R5_Patent_Part1.md

[^15]: R5_USPTO_Examiner_Review.md

[^16]: R4B Non-Provisional Parent Patent.pdf

[^17]: In the context of R4 briefly describe mechanistic.docx

[^18]: R4-R4A §101 Patent Eligibility Defense Strategy.docx

[^19]: R4-R4A §112(a) Enablement Defense Strategy.docx

[^20]: R4-R4A §112(b) Definiteness Defense Strategy.docx

[^21]: R4-R4A Claim Drafting Quality Strategy.docx

[^22]: improve r² = 0.54 unpredictable biological art.docx

[^23]: R4-R4A §102 Novelty Defense Strategy.docx

[^24]: CHL_PT_Ring_Provisional_Filing_Package.txt

[^25]: https://github.com/dsagman/picat

[^26]: https://github.com/amnweb/yasb/wiki/(Widget)-Whkd

[^27]: https://github.com/LGUG2Z/whkd

[^28]: https://github.com/docutain

[^29]: https://github.com/novuhq/novu

[^30]: https://github.com/zju3dv/IntrinsicAnything

[^31]: https://gist.github.com/navjack/32197772df1c0a8dbb8628676bc4e25a

[^32]: https://github.com/jasonppy/VoiceCraft

[^33]: https://github.com/intrinsic-ai

[^34]: https://github.com/Hackndo/The-Hacker-Recipes/blob/master/active-directory-domain-services/movement/abusing-ntlm/pass-the-hash.md

[^35]: https://github.com/berkus/wkdm

[^36]: https://github.com/joelparkerhenderson/architecture-decision-record

[^37]: https://github.com/irusanov/ZenTimings/issues/67

[^38]: https://github.com/gruns/icecream

[^39]: https://github.com/elder-plinius

[^40]: https://github.com/friendllcc/Malware-Detection-API-Sequence-Intrinsic-Features

[^41]: https://gist.github.com/kafene/0a6e259996862d35845784e6e5dbfc79

[^42]: https://github.com/AngleHony/WKTools

[^43]: https://timiskhakov.github.io/posts/haystacks-needles-and-hardware-intrinsics

[^44]: https://arxiv.org/html/2412.08139v1

[^45]: https://emailsecurity.blog/setting-up-wkd-for-automated-key-fetching

[^46]: https://www.intrinsic.ai/architecture

[^47]: https://github.com/JiamingLv/WKD

[^48]: https://github.com/cardwing/Codes-for-IntRA-KD/issues

[^49]: https://www.ietfng.org/nwf/_downloads/2e59e293c1afa58f0772fda209e6b54c/2023-cheri-isav9.pdf

[^50]: https://www.themoonlight.io/en/review/wasserstein-distance-rivals-kullback-leibler-divergence-for-knowledge-distillation

[^51]: https://www.youtube.com/watch?v=v0d7pMcas4Q

